[Polycythemia vera, clinical aspects and disease course]
- PMID: 648997
[Polycythemia vera, clinical aspects and disease course]
Abstract
The data of 140 patients with polycythemia vera during the period 1955--1975 were analyzed with regard to clinical signs and prognosis. The average age was 53,4 years. The sex ratio was 1.9:1 in favor of men. The most frequent symptoms were headache and vertigo. In more than half of the cases hepatosplenomegaly and hypertension were found. Besides typical changes in the blood count with elevated erythrocytes, hemoglobin, hematocrit, leukocytes and thrombocytes, increased levels of alkaline leukocyte phosphatase and uric acid were found. As to therapy, after 32P-medication the survival was two years longer than after phlebotomy. In 9 patients osteomyelofibrosis developed, and in 7 cases chronic myeloic leukemia. The mean age of death was 61 years.
Similar articles
-
[Polycythemia vera: clinical aspects and course in 86 patients].Schweiz Med Wochenschr. 1988 Dec 31;118(52):1969-75. Schweiz Med Wochenschr. 1988. PMID: 3217777 German.
-
Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.Semin Hematol. 1986 Apr;23(2):132-43. Semin Hematol. 1986. PMID: 3704665 Clinical Trial.
-
Neurologic complications of polycythemia and their impact on therapy.Oncology (Williston Park). 1990 Mar;4(3):59-64; discussion 64-6. Oncology (Williston Park). 1990. PMID: 2144446 Review.
-
Natural history and management of polycythemia vera.Adv Intern Med. 1979;24:255-85. Adv Intern Med. 1979. PMID: 371361 Review. No abstract available.
-
[Association of polycythemia vera and multiple myeloma. Presentation ofa new case and review of the literature].Sangre (Barc). 1993 Dec;38(6):497-9. Sangre (Barc). 1993. PMID: 8171387 Review. Spanish.
Cited by
-
[A contribution to the cytostatic long-term chemotherapy of polycythemia vera (author's transl)].Blut. 1979 Dec;39(6):399-403. doi: 10.1007/BF01008660. Blut. 1979. PMID: 519033 German.
-
Use and risks of phosphorus-32 in the treatment of polycythaemia vera.Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1413-7. doi: 10.1007/s00259-003-1270-6. Epub 2003 Sep 3. Eur J Nucl Med Mol Imaging. 2003. PMID: 12955483
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials